Amgen Europe B.V. (labeling, secondary packaging, batch release)

Ukraine

All drugs from this manufacturer

  • PARSABIV

    The drug is intended for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing hemodialysis.

    Dosage form: solution for injection

    Active substance Dosage
    etelcalcetide 5 mg/ml

    ATC: H05BX04